Pharma China (www.pharmachinaonline.com) is the most influential English media and source of business intelligence covering the Chinese pharmaceutical sector. Pharma China caters for the growing needs of the international pharmaceutical industry for up-to-date and insightful information and intelligence on China’s burgeoning but increasingly complex healthcare marketplace, and is subscribed by most MNC pharma companies, leading CROs, investment banks, consulting firms active in China as well as relevant industry associations and government agencies.

Note: To view full text of free articles, you need to register as a basic member first and then log in. To view premium articles, you need to subscribe to Pharma China as a premium member. For more information or subscription, please contact info@pharmachinaonline.com. If you wish to unsubscribe from this e-Alert, please reply this e-mail with "Remove" in the subject line.
Case Studies
GNC: China Strategy Hits Tariff Shoals(5/23/2019 )  (Premium)
Editor´s Picks
China: Survival of the Fittest or Cheapest?(5/22/2019 )  (Premium)
Is China The New Frontier For Indian Generics?(5/22/2019 )  (free)
Jack Ma Is Selling Cancer Coverage for Pennies a Month in China(5/21/2019 )  (Premium)
Diabetes Crisis Draws Challengers for $22 Billion Insulin Market(5/21/2019 )  (Premium)
FDA Defends Oversight Amid Questions of Safety of Generic Drugs Made in India and China(5/21/2019 )  (Premium)
Trade War With China Threatens To Make Problems With Generic Medicine Worse(5/21/2019 )  (Premium)
The Market
NH Reports 2018 Data on the Chinese OTC Analgesics Markets(5/22/2019 )  (Premium)
Industry News
Joinn Labs to Buy Clinical CRO Biomere for $27.3M(5/23/2019 )  (Premium)
WuXi STA and Dizal Pharma Sign CMC Development and Manufacturing Agreement(5/21/2019 )  (Premium)
WuXi Biologics Signed Letter of Intent for Long-Term Vaccine Manufacturing Contract(5/21/2019 )  (Premium)
Sandoz's Generic Rosuvastatin Cleared in China(5/21/2019 )  (Premium)
Mabpharm Announces Proposed Listing on Hong Kong Stock Exchange(5/21/2019 )  (Premium)
China Raises Tariffs on U.S. MedPharm Products to 25% as Part of Its Retaliatory Action(5/20/2019 )  (Premium)
General Health
Premier Li Urges More Efforts to Advance Healthcare Reforms(5/20/2019 )  (Premium)
Legal/IPR News
European Chamber Report Calls for Urgent China Reforms amid Increasing Global Challenges(5/21/2019 )  (Premium)
People in the News
Senior Chinese PharmChem Executive Arrested for Shipping 500 kilos of Drugs to the U.S.(5/23/2019 )  (Premium)
© Wicon International GroupˇˇSupport by: www.heightow.com Home | Site map | Contact Us | Links